Pandemic Timeline

Tag: spike proteins

UNC Chapel Hill files patent US7279327: Methods for producing recombinant coronavirus

A helper cell for producing an infectious, replication defective, coronavirus (or more generally nidovirus) particle cell comprises (a) a nidovirus permissive cell; (b) a nidovirus replicon RNA comprising the nidovirus packaging signal and a heterologous RNA sequence, wherein the replicon RNA further lacks a sequence encoding at least one nidovirus structural protein; and (c) at…

Ablynx files patent US9193780: Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases

The present invention relates in part to amino acid sequences that are directed against and/or that can specifically bind to an envelope protein of a virus, as well as to compounds or constructs, and in particular proteins and polypeptides, that comprise or essentially consist of one or more such amino acid sequences. — Patent US9193780B2…

“Vaccine-Induced Covid-19 Mimicry” Syndrome

As of April 2021, four adenovirus vector vaccines for COVID-19 have been authorized in at least one country: The Oxford–AstraZeneca vaccine uses the modified chimpanzee adenovirus ChAdOx1 Sputnik V uses human adenovirus serotype 26 for the first shot and serotype 5 for the second. The Johnson & Johnson vaccine uses serotype 26. Convidecia uses serotype 5. Research article excerpt: During the last months many countries have…

Study: Spike Protein impairs DNA damage repair

🔬 A new study published last month in the MDP Viruses Journal is titled, “SARS–CoV–2 Spike Impairs DNA Damage Repair and Inhibits V(D)J Recombination In Vitro.” It’s a little troubling for the injections, which make spike proteins. Remember that the “golden rule” of the mRNA injections was that the spike proteins wouldn’t get into cell…